An artificial intelligence-enabled electrocardiogram-based algorithm performed well in the early detection of heart failure ...

The blood test, known as the Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio, can be used to detect amyloid plaques ...

MDxHealth SA (MDXH) reports a 22% revenue increase and improved gross margins, while maintaining a disciplined approach to ...

New study shows radiomic features from mammograms enhance breast cancer prediction, particularly for false-negatives and ...

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both ...

CNW/ - Light AI Inc. ("Light AI" or the "Company") (CBOE CA: ALGO) (FSE: 0HC) (OTCQB: OHCFF), a healthcare technology company focused on developing ar ...

Key take-awaysEarly detection of left ventricular systolic dysfunction (LVSD) can identify patients at risk of developing ...

Discover a study that has proposed a predictive model for cirrhosis and hepatocellular carcinoma in individuals with ...

Changes in PROs can predict disease flares among patients with RA who discontinued csDMARD therapy after achieving sustained remission.

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both hormone-sensitive and ...

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both hormone-sensitive and castration-resistant patients.

Dick's (DKS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.